BlossomHill Therapeutics, Inc.
BLSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001839970
In the last 90 days, BlossomHill Therapeutics, Inc. insiders filed 5 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Superinvestors holding BLSM, Q2 2026
No superinvestor reported holding BLSM in Q2 2026.